Ophthalmic lens with an optically non-coaxial zone for myopia control

US11789292B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11789292-B2
Application numberUS-202117195840-A
CountryUS
Kind codeB2
Filing dateMar 9, 2021
Priority dateJan 22, 2018
Publication dateOct 17, 2023
Grant dateOct 17, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.

First claim

Opening claim text (preview).

What is claimed is: 1. An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression of a wearer, the ophthalmic lens comprising: a center zone centered around an optical axis, said center zone having a negative power for myopic vision correction of said wearer; and at least one treatment zone surrounding the center zone and disposed radially outward from the center zone, and centered around the optical axis, the at least one treatment zone having an ADD power relative to the center zone, wherein the at least one treatment zone has a surface shape derived from a portion of a torus wherein the surface shape is configured to direct light passing therethrough to form a continuous focal ring positioned in front of the retina of the wearer and around the optical axis, and wherein the surface shape of the at least one treatment zone forms a continuous surface with the center zone. 2. The ophthalmic lens of claim 1 , wherein the portion of the generally toroidal shape may be derived from a torus (e.g., a spheroidal torus), after making a slice in the shape of the surface of a right circular cone through the surface of the spheroidal torus wherein the principal axis of the cone is coincident with the axis of rotation about which the torus is generated. 3. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone is configured to minimize generation of a focal point behind a retinal plane of the eye of a wearer. 4. The ophthalmic lens according to claim 1 , further comprising a transition zone disposed between then center zone and the at least one treatment zone such that the at least one treatment zone, the transition zone, and the center zone form a continuous surface. 5. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone comprises an ADD power relative to the myopia correction power of greater than +5.00 D. 6. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone comprises an optical power from about −10.00 D to about +15.00 D. 7. The ophthalmic lens according to claim 1 , wherein a diameter of the center zone is about 2 mm to about 7 mm. 8. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone has an outer margin at about 4.5 mm from a center of the lens. 9. The ophthalmic lens according to claim 1 , wherein a halo effect is minimized. 10. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens comprises a contact lens. 11. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens comprises a spectacle lens. 12. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens comprises an intraocular lens, a corneal inlay, or a corneal onlay. 13. The ophthalmic according to claim 1 , further comprising one or more stabilization mechanisms. 14. The ophthalmic lens according to claim 1 , comprising: wherein the at least one treatment zone further comprises a tilt angle configured to direct an innermost ray relative to a cross section of the treatment zone to cross the optical axis at a point that is at or anterior to a retinal plane of a wearer of the ophthalmic lens. 15. The ophthalmic lens according to claim 14 , wherein the tilt angle is configured to direct the innermost ray to cross the optical axis at a point between the retinal plane and a point on the optical axis that represents a coincident point focus of the treatment zone. 16. The ophthalmic lens according to claim 14 , wherein the tilt angle is dependent upon an optical power of the treatment zone.

Assignees

Inventors

Classifications

  • G02C7/049Primary

    Contact lenses having special fitting or structural features achieved by special materials or material structures · CPC title

  • Inlays or onlays · CPC title

  • A61F2/1618Primary

    Multifocal lenses · CPC title

  • Ophthalmic lenses having special refractive features achieved by special materials or material structures (G02C7/049 takes precedence) · CPC title

  • Myopia progression prevention · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11789292B2 cover?
The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone…
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification G02C7/049. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).